Results 11 to 20 of about 641 (114)

Ginkgo biloba extract individually inhibits JNK activation and induces c-Jun degradation in human chondrocytes: potential therapeutics for osteoarthritis. [PDF]

open access: yesPLoS ONE, 2013
Osteoarthritis (OA) is a common joint disorder with varying degrees of inflammation. The ideal anti-OA drug should have immunomodulatory effects while at the same time having limited or no toxicity.
Ling-Jun Ho   +6 more
doaj   +1 more source

Effects of Ginkgo biloba Extract EGb 761, Donepezil and their Combination on Central Cholinergic Function in Aged Rats

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2015
Purpose. Ginkgo extract EGb 761 and cholinesterase inhibitors have been shown to be effective in the treatment of dementia patients. In addition to neuroprotective effects, Ginkgo extract EGb 761 has been reported to elevate brain levels of certain ...
Christoph Stein   +3 more
doaj   +1 more source

Ultrastructural analysis of kidney, liver and duodenum isolated from treated rats with Ginkgo Biloba extract and effects of this medicinal plant on the biodistribution of the padiopharmaceutical sodium pertechnetate

open access: yesBrazilian Archives of Biology and Technology, 2008
Ginkgo biloba extract (EGb) has been used to treat memory and concentration deficits, acts as platelet activating factor antagonism and prevents against damages caused by free radicals.
Silvana Ramos Farias Moreno   +7 more
doaj   +1 more source

Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial

open access: yesFrontiers in Pharmacology, 2023
Background: Patients who experienced an ischemic stroke are at risk for cognitive impairment. Quantified Ginkgo biloba extract EGb 761® has been used to treat cognitive dysfunction, functional impairment and neuropsychiatric symptoms in mild cognitive ...
Mei Cui   +8 more
doaj   +1 more source

Hyperbaric Oxygen and Ginkgo Biloba Extract Ameliorate Cognitive and Memory Impairment via Nuclear Factor Kappa-B Pathway in Rat Model of Alzheimer′s Disease

open access: yesChinese Medical Journal, 2015
Background: Hyperbaric oxygen (HBO) and Ginkgo biloba extract (e.g., EGB 761) were shown to ameliorate cognitive and memory impairment in Alzheimer′s disease (AD). However, the exact mechanism remains elusive.
Li-Da Zhang   +6 more
doaj   +1 more source

Einstein-Gauss-Bonnet black rings at large D

open access: yesJournal of High Energy Physics, 2018
We study the black ring solution in the Einstein-Gauss-Bonnet (EGB) theory at large D. By using the 1/D expansion in the near horizon region we derive the effective equations for the slowly rotating black holes in the EGB theory.
Bin Chen   +2 more
doaj   +1 more source

Combined treatment with Ginkgo biloba extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment

open access: yesAlzheimer’s & Dementia: Translational Research & Clinical Interventions, 2022
Introduction Mild cognitive impairment (MCI) is a neurocognitive state between normal aging and dementia. There is currently no approved treatment for MCI, with acetylcholinesterase inhibitors (AChEI) being the commonly prescribed drugs.
José María García‐Alberca   +2 more
doaj   +1 more source

Standardized extract of Ginkgo biloba enhances memory persistence over time

open access: yesPhytomedicine Plus, 2023
Background: Previously, our group has shown that treatment with a standardized extract of Ginkgo biloba leaves (EGb) before acquisition/encoding of the conditioned suppression and object recognition task produced recent memory persistence by upregulating
Andressa Gabriela Soliani   +4 more
doaj   +1 more source

EGb 761

open access: yesDrugs in R & D, 2003
EGb 761 [Ginkgo biloba extract EGb 761, Rökan, Tanakan, Tebonin] is a standardised extract of Ginkgo biloba leaves and has antioxidant properties as a free radical scavenger. A standardised extract of Ginkgo biloba leaves is a well defined product and contains approximately 24% flavone glycosides (primarily quercetin, kaempferol and isorhamnetin) and 6%
openaire   +2 more sources

Home - About - Disclaimer - Privacy